YD Bio Limited (YDES)
Nasdaq: YDES · Services-Medical Laboratories · Irving, TX · filing with the SEC since 2024
Who runs YD Bio Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Shen Ethan Phd
CEO. First filing Mar 2026, latest Sep 16, 2026, 3 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
6 people on the record since 2026
Officerssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Shen Ethan Phd | CEO | Mar 2026 | Sep 16, 2026 | none |
| Zhang Bo-Xiang | Chief Medical Officer | Mar 2026 | Mar 27, 2026 | none |
| Hen Man Edmund | Chief Financial Officer | Mar 2026 | Mar 26, 2026 | none |
Directorssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chang Kochi | director | Mar 2026 | Oct 6, 2026 | none |
| Lu Shao-Ta | director | Mar 2026 | Oct 6, 2026 | none |
| Lee Jerry Yin-Chia | director | Mar 2026 | Mar 30, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.